C0220825||Evaluation
C0348016||Intravenous
C0522523||Percutaneous
C0279027||Low Level Laser Therapy
C0002766||Management
C0037004||Shoulder
C0027073||Myofascial Pain Syndrome
C0027073||Myofascial pain syndrome
C0027073||Myofascial pain syndrome
C0087111||treatment
C0087111||treatment frame
C0087111||treatment
C0348016||intravenous
C1955835||laser therapy
C1955835||intravenous laser therapy
C0522523||percutaneous
C0279027||low level laser
C0279027||percutaneous low level laser
C0002766||management
C0037004||shoulder
C0027073||Myofascial pain syndrome
C0206035||randomized controlled trial
C1257890||intravenous laser therapy
C1257890||percutaneous low level laser
C1706408||placebo
C0279027||low level laser
C1257890||IVL group
C1955835||IVL therapy
C1257890||PLLL group
C0279027||PLLL therapy
C0150347||gentle massage
C0458343||trigger points
C0600080||stretching exercises
C0026845||muscle
C0224361||trapezius
C0442027||oral
C0028420||nortriptyline
C0040808||regimen
C4050142||Numeric Rating Scale
C4050142||Numeric Rating Scale
C0282574||Pain Disability Index
C0282574||Pain Disability Index
C0451286||Short Form Health Survey
C1519135||SF-12
C4019276||Data collected
C0936012||analyzed
C1708930||Mann-Whitney
C0871472||t tests
C0282574||Pain Disability Index
C1320357||pain intensity
C1257890||percutaneous low level laser
C1257890||IVL groups
C0282574||Pain Disability Index
C1257890||IVL group
C1257890||PLLL group
C1257890||intravenous laser therapy
C1257890||PLLL groups
C1257890||IVL group
C1257890||PLLL group
C1963761||No side effects
C2986530||intervention groups
C0348016||Intravenous
C1955835||laser
C0279027||PLLL therapy
C0282574||Pain Disability Index
C1963761||no adverse event
C0348016||intravenous
C1955835||lasers
C0279027||PLLL therapy
C0002766||managing
C0037004||shoulder
C0027073||Myofascial pain syndrome